A novel nonsense mutation of ERCC2 in a Vietnamese family with xeroderma pigmentosum syndrome group D
Open Access
- 10 February 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in Human Genome Variation
- Vol. 7 (1), 1-8
- https://doi.org/10.1038/s41439-020-0089-z
Abstract
Xeroderma pigmentosum (XP) group D, a severe disease often typified by extreme sun sensitivity, can be caused by ERCC2 mutations. ERCC2 encodes an adenosine triphosphate (ATP)-dependent DNA helicase, namely XP group D protein (XPD). The XPD, one of ten subunits of the transcription factor TFIIH, plays a critical role in the nucleotide-excision repair (NER) pathway. Mutations in XPD that affect the NER pathway can lead to neurological degeneration and skin cancer, which are the most common causes of death in XP patients. Here, we present detailed phenotypic information on a Vietnamese family in which four members were affected by XP with extreme sun sensitivity. Genomic analysis revealed a compound heterozygous mutation of ERCC2 that affected family members and single heterozygous mutations in unaffected family members. We identified a novel, nonsense mutation in one allele of ERCC2 (c.1354C > T, p.Q452X) and a known missense mutation in the other allele (c.2048G > A, p.R683Q). Fibroblasts isolated from the compound heterozygous subject also failed to recover from UV-driven DNA damage, thus recapitulating aspects of XP syndrome in vitro. We describe a novel ERCC2 variant that leads to the breakdown of the NER pathway across generations of a family presenting with severe XP.Keywords
This publication has 14 references indexed in Scilit:
- Patients with xeroderma pigmentosum complementation groups C, E and V do not have abnormal sunburn reactionsBritish Journal of Dermatology, 2013
- A novel XPD mutation in a compound heterozygote; the mutation in the second allele is present in three homozygous patients with mild sun sensitivityEnvironmental and Molecular Mutagenesis, 2012
- Strict sun protection results in minimal skin changes in a patient with xeroderma pigmentosum and a novel c.2009delG mutation in XPD (ERCC2)Experimental Dermatology, 2008
- Trichothiodystrophy: a systematic review of 112 published cases characterises a wide spectrum of clinical manifestationsJournal of Medical Genetics, 2008
- Persistence of repair proteins at unrepaired DNA damage distinguishes diseases withERCC2(XPD) mutations: cancer-prone xeroderma pigmentosum vs. non-cancer-prone trichothiodystrophyHuman Mutation, 2008
- Mutations in the XPD gene in xeroderma pigmentosum group D cell strains: Confirmation of genotype‐phenotype correlationAmerican Journal of Medical Genetics, 2002
- Two individuals with features of both xeroderma pigmentosum and trichothiodystrophy highlight the complexity of the clinical outcomes of mutations in the XPD geneHuman Molecular Genetics, 2001
- Cerebro-Oculo-Facio-Skeletal Syndrome with a Nucleotide Excision–Repair Defect and a Mutated XPD Gene, with Prenatal Diagnosis in a Triplet PregnancyAmerican Journal of Human Genetics, 2001
- Xeroderma pigmentosum and trichothiodystrophy are associated with different mutations in the XPD ( ERCC 2) repair/transcription geneProceedings of the National Academy of Sciences of the United States of America, 1997
- Mutations in theXPD gene leading to xeroderma pigmentosum symptomsHuman Mutation, 1997